Article Details
Retrieved on: 2021-08-04 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
"Rgenta's unique RNA-targeting approach is well-suited for neuroscience targets and small-molecule RNA-targeting drugs have many advantages over ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here